> top > docs > PMC:2222968 > spans > 1103-1799 > annotations

PMC:2222968 / 1103-1799 JSONTXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T280 0-15 NN denotes transactivation
T281 16-23 NN denotes process
T282 25-34 RB denotes Therefore
T283 34-35 -COMMA- denotes ,
T284 36-40 DT denotes this
T285 41-46 NN denotes study
T286 47-55 VB denotes provides
T287 56-57 DT denotes a
T288 58-61 JJ denotes new
T289 62-75 NN denotes understanding
T290 76-78 IN denotes of
T291 79-88 NN denotes tolerance
T292 89-100 NN denotes development
T293 100-101 -COMMA- denotes ,
T294 102-112 VB denotes controlled
T295 113-115 IN denotes by
T296 116-117 DT denotes a
T297 118-122 NN denotes type
T298 123-124 CD denotes 2
T299 125-131 JJ denotes immune
T300 132-140 NN denotes response
T301 142-146 NN denotes IL-4
T302 147-156 NN denotes treatment
T303 157-159 IN denotes in
T304 160-164 NN denotes mice
T305 165-172 VB denotes reduces
T306 173-178 NN denotes iTreg
T307 179-183 NN denotes cell
T308 184-193 NN denotes frequency
T309 193-194 -COMMA- denotes ,
T310 195-207 VB denotes highlighting
T311 208-212 IN denotes that
T312 213-224 JJ denotes therapeutic
T313 225-235 NN denotes approaches
T314 236-240 WDT denotes that
T315 241-247 VB denotes target
T316 248-252 NN denotes IL-4
T317 253-255 CC denotes or
T318 256-261 NN denotes GATA3
T319 262-267 MD denotes might
T320 268-275 VB denotes provide
T321 276-279 JJ denotes new
T322 280-290 JJ denotes preventive
T323 291-301 NN denotes strategies
T324 302-314 VB denotes facilitating
T325 315-324 NN denotes tolerance
T326 325-334 NN denotes induction
T327 335-347 RB denotes particularly
T328 348-350 IN denotes in
T329 351-363 JJ denotes Th2-mediated
T330 364-372 NN denotes diseases
T331 372-373 -COMMA- denotes ,
T332 374-378 JJ denotes such
T333 379-381 IN denotes as
T334 382-389 NN denotes allergy
R227 T281 T280 arg1Of process,transactivation
R228 T285 T284 arg1Of study,this
R229 T285 T286 arg1Of study,provides
R230 T286 T282 arg1Of provides,Therefore
R231 T286 T283 arg1Of provides,","
R232 T289 T286 arg2Of understanding,provides
R233 T289 T287 arg1Of understanding,a
R234 T289 T288 arg1Of understanding,new
R235 T289 T290 arg1Of understanding,of
R236 T289 T293 arg1Of understanding,","
R237 T289 T294 arg2Of understanding,controlled
R238 T292 T290 arg2Of development,of
R239 T292 T291 arg1Of development,tolerance
R240 T300 T294 arg1Of response,controlled
R241 T300 T295 arg2Of response,by
R242 T300 T296 arg1Of response,a
R243 T300 T297 arg1Of response,type
R244 T300 T298 arg1Of response,2
R245 T300 T299 arg1Of response,immune
R246 T302 T301 arg1Of treatment,IL-4
R247 T302 T303 arg1Of treatment,in
R248 T302 T305 arg1Of treatment,reduces
R249 T302 T310 arg1Of treatment,highlighting
R250 T304 T303 arg2Of mice,in
R251 T305 T309 arg1Of reduces,","
R252 T305 T310 modOf reduces,highlighting
R253 T308 T305 arg2Of frequency,reduces
R254 T308 T306 arg1Of frequency,iTreg
R255 T308 T307 arg1Of frequency,cell
R256 T313 T312 arg1Of approaches,therapeutic
R257 T313 T314 arg1Of approaches,that
R258 T313 T315 arg1Of approaches,target
R259 T313 T319 arg1Of approaches,might
R260 T313 T320 arg1Of approaches,provide
R261 T316 T317 arg1Of IL-4,or
R262 T317 T315 arg2Of or,target
R263 T318 T317 arg2Of GATA3,or
R264 T320 T310 arg2Of provide,highlighting
R265 T320 T311 arg1Of provide,that
R266 T320 T319 arg2Of provide,might
R267 T320 T328 arg1Of provide,in
R268 T323 T320 arg2Of strategies,provide
R269 T323 T321 arg1Of strategies,new
R270 T323 T322 arg1Of strategies,preventive
R271 T323 T324 arg1Of strategies,facilitating
R272 T326 T324 arg2Of induction,facilitating
R273 T326 T325 arg1Of induction,tolerance
R274 T328 T327 arg1Of in,particularly
R275 T330 T328 arg2Of diseases,in
R276 T330 T329 arg1Of diseases,Th2-mediated
R277 T330 T331 arg1Of diseases,","
R278 T330 T333 arg1Of diseases,as
R279 T333 T332 arg1Of as,such
R280 T334 T333 arg2Of allergy,as

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T542 0-15 NN denotes transactivation
T543 16-23 NN denotes process
T544 23-24 . denotes .
T545 25-34 RB denotes Therefore
T546 34-35 , denotes ,
T547 36-40 DT denotes this
T548 41-46 NN denotes study
T549 47-55 VBZ denotes provides
T550 56-57 DT denotes a
T551 58-61 JJ denotes new
T552 62-75 NN denotes understanding
T553 76-78 IN denotes of
T554 79-88 NN denotes tolerance
T555 89-100 NN denotes development
T556 100-101 , denotes ,
T557 102-112 VBN denotes controlled
T558 113-115 IN denotes by
T559 116-117 DT denotes a
T560 118-122 NN denotes type
T561 123-124 CD denotes 2
T562 125-131 JJ denotes immune
T563 132-140 NN denotes response
T564 140-141 . denotes .
T565 142-146 NN denotes IL-4
T566 147-156 NN denotes treatment
T567 157-159 IN denotes in
T568 160-164 NNS denotes mice
T569 165-172 VBZ denotes reduces
T570 173-178 NNP denotes iTreg
T571 179-183 NN denotes cell
T572 184-193 NN denotes frequency
T573 193-194 , denotes ,
T574 195-207 VBG denotes highlighting
T575 208-212 IN denotes that
T576 213-224 JJ denotes therapeutic
T577 225-235 NNS denotes approaches
T578 236-240 WDT denotes that
T579 241-247 VBP denotes target
T580 248-252 NN denotes IL-4
T581 253-255 CC denotes or
T582 256-261 NN denotes GATA3
T583 262-267 MD denotes might
T584 268-275 VB denotes provide
T585 276-279 JJ denotes new
T586 280-290 JJ denotes preventive
T587 291-301 NNS denotes strategies
T588 302-314 VBG denotes facilitating
T589 315-324 NN denotes tolerance
T590 325-334 NN denotes induction
T591 335-347 RB denotes particularly
T592 348-350 IN denotes in
T593 351-363 JJ denotes Th2-mediated
T594 364-372 NNS denotes diseases
T595 372-373 , denotes ,
T596 374-378 JJ denotes such
T597 379-381 IN denotes as
T598 382-389 NN denotes allergy
T599 389-390 . denotes .
R462 T542 T543 compound transactivation,process
R465 T545 T549 advmod Therefore,provides
R466 T546 T549 punct ",",provides
R467 T547 T548 det this,study
R468 T548 T549 nsubj study,provides
R469 T549 T549 ROOT provides,provides
R470 T550 T552 det a,understanding
R471 T551 T552 amod new,understanding
R472 T552 T549 dobj understanding,provides
R473 T553 T552 prep of,understanding
R474 T554 T555 compound tolerance,development
R475 T555 T553 pobj development,of
R476 T556 T552 punct ",",understanding
R477 T557 T552 acl controlled,understanding
R478 T558 T557 agent by,controlled
R479 T559 T563 det a,response
R480 T560 T563 nmod type,response
R481 T561 T560 nummod 2,type
R482 T562 T563 amod immune,response
R483 T563 T558 pobj response,by
R484 T564 T549 punct .,provides
R485 T565 T566 compound IL-4,treatment
R486 T566 T569 nsubj treatment,reduces
R487 T567 T566 prep in,treatment
R488 T568 T567 pobj mice,in
R489 T569 T569 ROOT reduces,reduces
R490 T570 T572 compound iTreg,frequency
R491 T571 T572 compound cell,frequency
R492 T572 T569 dobj frequency,reduces
R493 T573 T569 punct ",",reduces
R494 T574 T569 advcl highlighting,reduces
R495 T575 T584 mark that,provide
R496 T576 T577 amod therapeutic,approaches
R497 T577 T584 nsubj approaches,provide
R498 T578 T579 nsubj that,target
R499 T579 T577 relcl target,approaches
R500 T580 T579 dobj IL-4,target
R501 T581 T580 cc or,IL-4
R502 T582 T580 conj GATA3,IL-4
R503 T583 T584 aux might,provide
R504 T584 T574 ccomp provide,highlighting
R505 T585 T587 amod new,strategies
R506 T586 T587 amod preventive,strategies
R507 T587 T584 dobj strategies,provide
R508 T588 T584 advcl facilitating,provide
R509 T589 T590 compound tolerance,induction
R510 T590 T588 dobj induction,facilitating
R511 T591 T592 advmod particularly,in
R512 T592 T590 prep in,induction
R513 T593 T594 amod Th2-mediated,diseases
R514 T594 T592 pobj diseases,in
R515 T595 T594 punct ",",diseases
R516 T596 T597 amod such,as
R517 T597 T594 prep as,diseases
R518 T598 T597 pobj allergy,as
R519 T599 T569 punct .,reduces

GO-BP

Id Subject Object Predicate Lexical cue
T71 0-15 http://purl.obolibrary.org/obo/GO_2000144 denotes transactivation
T72 89-100 http://purl.obolibrary.org/obo/GO_0032502 denotes development
T73 125-140 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T74 132-146 http://purl.obolibrary.org/obo/GO_0071353 denotes response. IL-4
T75 132-146 http://purl.obolibrary.org/obo/GO_0070670 denotes response. IL-4
T76 315-334 http://purl.obolibrary.org/obo/GO_0002507 denotes tolerance induction

GO-MF

Id Subject Object Predicate Lexical cue
T632 142-146 http://purl.obolibrary.org/obo/GO_0005136 denotes IL-4
T633 248-252 http://purl.obolibrary.org/obo/GO_0005136 denotes IL-4

GO-CC

Id Subject Object Predicate Lexical cue
T639 179-183 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

sentences

Id Subject Object Predicate Lexical cue
T65 25-141 Sentence denotes Therefore, this study provides a new understanding of tolerance development, controlled by a type 2 immune response.
T66 142-390 Sentence denotes IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy.
T9 25-141 Sentence denotes Therefore, this study provides a new understanding of tolerance development, controlled by a type 2 immune response.
T10 142-390 Sentence denotes IL-4 treatment in mice reduces iTreg cell frequency, highlighting that therapeutic approaches that target IL-4 or GATA3 might provide new preventive strategies facilitating tolerance induction particularly in Th2-mediated diseases, such as allergy.
T11 392-406 Sentence denotes Author Summary
T12 408-621 Sentence denotes Specific immune responses against foreign or autologous antigens are driven by specialized epitope-specific T cells, whose numbers expand upon recognition of antigen found on professional antigen-presenting cells.

ICD10

Id Subject Object Predicate Lexical cue
T630 382-389 http://purl.bioontology.org/ontology/ICD10/T78.4 denotes allergy

events-check-again

Id Subject Object Predicate Lexical cue
T777 142-146 Protein denotes IL-4
T778 241-247 Regulation denotes target
T779 241-247 Regulation denotes target
T780 248-252 Protein denotes IL-4
T781 256-261 Protein denotes GATA3
R607 T780 T778 themeOf IL-4,target
R608 T781 T779 themeOf GATA3,target

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T666 142-146 Protein denotes IL-4
T667 241-252 Protein denotes target IL-4
T668 256-261 Protein denotes GATA3

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue
T81 241-247 Regulation denotes target
T82 241-247 Regulation denotes target
T95 142-146 Protein denotes IL-4
T96 248-252 Protein denotes IL-4
T97 256-261 Protein denotes GATA3
R627 T96 T81 themeOf IL-4,target
R628 T97 T82 themeOf GATA3,target

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T349 142-146 P05112 denotes IL-4
T350 248-252 P05112 denotes IL-4
T351 256-261 P23771 denotes GATA3

test2

Id Subject Object Predicate Lexical cue
T53 142-146 Protein denotes IL-4
T54 241-247 Binding denotes target
T55 248-252 Protein denotes IL-4
T56 256-261 Protein denotes GATA3
R36 T53 T54 themeOf IL-4,target
R37 T55 T54 themeOf IL-4,target
R38 T56 T54 themeOf GATA3,target